Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Small but interesting case series suggests step-up test in which pts develop a heart rate >120 after 50 step-ups and HR recovery >3 min may predict risk of movement and neurocognitive treatment-emergent events after cilta-cel.”
Title: Pretreatment physical function as a risk factor for movement and neurocognitive treatment-emergent events (MNTs) in multiple myeloma (MM) patients treated with cilta-cel
Authors: Megan M. Herr, Nisha M. Nair, Theresa Hahn, Chelsea Peterson, Jens Hillengass, Hillary Jacobson, Grant Schofield, Philip L. McCarthy, Ehsan Malek, Renee McKenzie, Hamza Hassan, Joseph D. Tario, Jr, Maureen Ross, Marco L. Davila, Brian C. Betts, and Shernan Holtan.
You can read the Full Article in the Journal of the Neurological Sciences.
You can find more posts featuring Robert Orlowski on OncoDaily.
